Breast Cancer During Pregnancy (BRCAPRE)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by Hospital Universitari Vall d'Hebron Research Institute
Sponsor:
Information provided by (Responsible Party):
Hospital Universitari Vall d'Hebron Research Institute
ClinicalTrials.gov Identifier:
NCT02102282
First received: March 29, 2014
Last updated: April 1, 2014
Last verified: March 2014

March 29, 2014
April 1, 2014
October 2012
December 2022   (final data collection date for primary outcome measure)
Perinatal results [ Time Frame: Delivery ] [ Designated as safety issue: Yes ]
Gestational age, weight, Apgar, blood tests
Same as current
Complete list of historical versions of study NCT02102282 on ClinicalTrials.gov Archive Site
Maternal outcome [ Time Frame: 5 year and 10 year ] [ Designated as safety issue: Yes ]
Over all survival, disease free survival
Same as current
Not Provided
Not Provided
 
Breast Cancer During Pregnancy
Observational Study of Breast Cancer Diagnosed During Pregnancy

Patients are managed clinically according to ad hoc standards and scientific knowledge by a multidisciplinary team. Clinical decisions are made after a patient physician discussion. Blood and tissue samples are collected. Diagnostic, obstetric management surgical treatment, systemic treatment, perinatal results and follow up data are collected.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

Blood and tissue samples

Non-Probability Sample

Patients with breast cancer diagnosed during pregnancy

  • Pregnancy
  • Breast Cancer
Not Provided
Subject study
Patients with breast cancer during pregnancy

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
30
Not Provided
December 2022   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with breast cancer diagnosed during pregnancy

Exclusion Criteria:

  • Patients who refuse informed consent
Female
18 Years to 60 Years
No
Contact: Octavi Cordoba, PhD 34934893184 ocordoba@vhebron.net
Contact: Cristina Saura, MD 34934893105 csaura@vhebron.net
Spain
 
NCT02102282
PR(AMI)83/2012
No
Hospital Universitari Vall d'Hebron Research Institute
Hospital Universitari Vall d'Hebron Research Institute
Not Provided
Principal Investigator: Octavi Cordoba, PhD MD Hospital Universitari Vall d'Hebron
Hospital Universitari Vall d'Hebron Research Institute
March 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP